Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

American Academy of Neurology, April 13-18

The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including...

CDC Launches Online Tool to Help Americans Manage Extreme Heat

TUESDAY, April 23, 2024 -- The U.S. Centers for Disease Control and Prevention has launched a new online heat forecaster to help communities better prepare...

FDA Urges Public to Use Heimlich Not 'Anti-Choking' Devices to Save Lives

TUESDAY, April 23, 2024 -- The U.S. Food and Drug Administration is advising people to use the Heimlich maneuver to aid a choking victim and not rely on...

Few Cancer Survivors Fully Adherent to ACS Nutrition and Physical Activity Guidelines

TUESDAY, April 23, 2024 -- Only 4 percent of cancer survivors are fully adherent to current American Cancer Society (ACS) nutrition and physical activity...

Antihypertensive Meds Initiation Linked to Fractures in Nursing Home Seniors

TUESDAY, April 23, 2024 -- For longer-term nursing home residents, initiation of antihypertensive medication is associated with an increased risk for fractures...

Cancer Takes Tough Toll on Family Finances

TUESDAY, April 23, 2024 -- About six out of 10 working-age adults hit with a cancer diagnosis say it put real pressure on their financial survival, a new...

Neosporin Ointment in the Nose Might Be Potent Antibiotic

TUESDAY, April 23, 2024 -- Want to prevent a respiratory infection? A fingerful of Neosporin antibiotic swabbed inside your nose might help you fight off a...

Taking Psilocybin for Depression? Relationship With Therapist Is Key

TUESDAY, April 23, 2024 -- Many people dogged by depression are turning to the psilocybin found in "magic mushrooms" to ease the condition, and often reporting...

Repeat Blasts Can Damage Soldiers' Brains, Study Confirms

TUESDAY, April 23, 2024 -- Soldiers can suffer brain injury if they are repeatedly exposed to explosive blasts, a new study shows. Further, the more...

Women in the Military at Risk for Low-Weight Babies

TUESDAY, April 23, 2024 -- Active military service appears to increase a woman’s risk of having a low birthweight baby, a new review finds. Nearly...

Abeona Therapeutics Provides Regulatory Update on Pz-cel

CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel)...

FDA Approves Anktiva (nogapendekin alfa inbakicept-pmln) Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

CULVER CITY, Calif., April 22, 2024 -- ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration...

U.S. FDA Approves Subcutaneous Administration of Takeda’s Entyvio (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease

OSAKA, Japan April 19, 2024 and CAMBRIDGE, Massachusetts, April 18, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug...

FDA Approves Lumisight (pegulicianine) Optical Imaging Agent to Illuminate Residual Breast Cancer Post-Lumpectomy

NEWTON, Mass.--(BUSINESS WIRE) April 18, 2024 --Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging...

FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer

South San Francisco, CA -- April 18, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug...

FDA Approves Selarsdi (ustekinumab-aekn), a Biosimilar to Stelara

REYKJAVIK, Iceland & PARSIPPANY, N.J.--(BUSINESS WIRE) April 16, 2024 --Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva...

Supernus Provides Regulatory Update for SPN-830

ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

Stealth Biotherapeutics Announces FDA Acceptance of New Drug Application for Elamipretide for the Treatment of Barth Syndrome

NEEDHAM, Mass., April 8, 2024 /PRNewswire/ — Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and...

Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer

DUBLIN, April 2, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has completed the rolling submission of a...

Datopotamab Deruxtecan Biologics License Application Accepted in the US for Patients with Previously Treated Metastatic HR-Positive, HER2-Negative Breast Cancer

2 April 2024 -- AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...

Endevica Bio drug candidate shows success in weight loss in new study

NORTHBROOK, Ill., April 23, 2024 - Endevica Bio, a company developing first-in-class peptide drug candidates, announced its novel weight-loss treatment was...

FDA Approves Clinical Trial for GFH925 Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer

SHANGHAI, April 19, 2024. GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology...

Doctors Underutilize Next-Gen Antibiotics to Fight Resistant Infections in U.S. Hospitals

April 19, 2024 -- Despite Food and Drug Administration (FDA)-approval of seven next-generation antibiotics to fight infections caused by resistant...

AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure

Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company...

NIH Researchers Develop AI Tool with Potential to More Precisely Match Cancer Drugs to Patients

April 18, 2024 -- In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.